MH
Michael H. Mulroy bought $26K of LCTX stock
Michael H. Mulroy, Dir of Lineage Cell Therapeutics, Inc. (LCTX), bought 30,000 shares of LCTX stock worth $26K, per an SEC Form 4 filed Nov 19, 2026.
It was an open-market purchase.
The trade happened on Nov 17, 2026, 2 days before it was made public.
LCTX has moved +0.5% since the trade date, from $0.82 to $0.82 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Price since
- +0.5%
- Role
- Dir
- Source
- SEC Form 4